title: Sight-threatening keratopathy complicating anti-TNF therapy in Crohn's disease: a case report.
authors.affiliation: *Gastrointestinal Unit, Western General Hospital, Edinburgh, United Kingdom †Princess Alexandra Eye Pavilion, Edinburgh, United Kingdom ‡Inverclyde Royal Hospital Greenock, Renfrewshire, United Kingdom.
authors.forename: Federica
authors.initials: F
authors.lastname: Fasci-Spurio
authors.forename: Alexandra
authors.initials: A
authors.lastname: Thompson
authors.forename: Stephen
authors.initials: S
authors.lastname: Madill
authors.forename: Peter
authors.initials: P
authors.lastname: Koay
authors.forename: David
authors.initials: D
authors.lastname: Mansfield
authors.forename: Jack
authors.initials: J
authors.lastname: Satsangi
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003316:Corneal Diseases / Q000139:chemically induced* / Q000473:pathology; D060527:Corneal Keratocytes / Q000187:drug effects / Q000473:pathology; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008297:Male; D011379:Prognosis; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014792:Visual Acuity / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab